Gamida CellCompany Details

Get alertedif Gamida Cell gets funded!
Detailed industries:biotechnology
Company description

Gamida Cell Gamida Cell is currently engaged in a Phase I/II study of NiCord® as an investigational therapeutic treatment for hematological malignancies such as leukemia and lymphoma.


Funding history

Key people
Naftali BrikashviliCFO
Dorit HaratiVP, Quality Assurance
Ruben KrupikChairman of the Board
Frederick M. MiesowiczVice President of U.S. Operations
Yael MargolinPresident, CEO & Board of Directors
Tony PeledCo - Founder, Chief Scientific Officer & VP, R&D
David SnyderVP, Clinical Development & Regulatory Affairs
Please note that all data is automatically extracted and errors can occur.
The WhoGotFunded team has not necessarily reviewed the information in this page and has not determined if it is accurate and complete.
Inaccurate Data? Help us improve WhoGotFunded: post a comment!